Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT Report

iCD Research
February 4, 2012
22 Pages - SKU: ICDR6793089
License type:
Synopsis

ICD Research's Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

ICD Research's Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Octapharma AG.

ICD Research's Octapharma AG: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about Octapharma AG for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of Octapharma AG .
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

Octapharma AG (Octapharma) develops, produces and distributes finished plasma products around the world. The company is focused on the research and development of human proteins in the fields of haematology, immunotherapy, intensive care and emergency medicine. It offers a variety of plasma products for the treatment of coagulation disorders and immune diseases. In addition to plasma products, Octapharma offers plasma-based services such as supporting self-sufficiency partners and providing technology transfers through licensing. The company operates six production facilities located in Austria, France, Germany, Sweden and Mexico. In addition it operates 54 plasma donation centers and 62 plasma collection centers in the US and Europe. The company operates through 37 subsidiaries and representative offices in over 80 countries. Octapharma is headquartered in Lachen, Switzerland.